Correlation Between Bristol-Myers Squibb and Helio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Helio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Helio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Helio, you can compare the effects of market volatilities on Bristol-Myers Squibb and Helio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Helio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Helio.

Diversification Opportunities for Bristol-Myers Squibb and Helio

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bristol-Myers and Helio is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Helio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helio and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Helio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helio has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Helio go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Helio

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Helio. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 10.34 times less risky than Helio. The pink sheet trades about -0.15 of its potential returns per unit of risk. The Helio is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  492.00  in Helio on November 3, 2024 and sell it today you would earn a total of  208.00  from holding Helio or generate 42.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Helio

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Helio 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Helio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile technical and fundamental indicators, Helio displayed solid returns over the last few months and may actually be approaching a breakup point.

Bristol-Myers Squibb and Helio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Helio

The main advantage of trading using opposite Bristol-Myers Squibb and Helio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Helio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helio will offset losses from the drop in Helio's long position.
The idea behind Bristol Myers Squibb and Helio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities